Stocktoria
Zentalis Pharmaceuticals, Inc. ZNTL
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-04-03
Chart by TradingView
2/9
Piotroski F — financial health
-8.96
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $0 | $67.4M | $0 | $0 | — |
| Operating income | -$152.8M | -$191.2M | -$299.5M | -$227.3M | -$216.5M |
| Net income | -$137.1M | -$165.8M | -$292.2M | -$236.8M | -$158.7M |
| Operating cash flow | -$125.2M | -$170.9M | -$207.8M | -$163.8M | -$154.1M |
| Free cash flow | -$125.2M | -$171.1M | -$208.4M | -$166.3M | -$160.2M |
| Total assets | $289.0M | $430.3M | $551.7M | $539.3M | $454.5M |
| Total liabilities | $72.8M | $93.2M | $114.3M | $105.3M | $90.0M |
| Shareholders' equity | $216.2M | $337.2M | $437.4M | $434.0M | $364.5M |
| Ratios | |||||
| Operating margin | — | -283.6% | — | — | — |
| Net margin | — | -246.0% | — | — | — |
| FCF margin | — | -253.7% | — | — | — |
| Return on assets | -47.4% | -38.5% | -53.0% | -43.9% | -34.9% |
| Return on equity | -63.4% | -49.2% | -66.8% | -54.6% | -43.5% |
| Current ratio | 6.93 | 7.32 | 7.16 | 7.98 | 7.98 |
| Revenue growth | -100.0% | — | — | — | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 1,938,145 | $4.5M |
| Point72 Asset Management, L.P. | 94,854 | $221,958 |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -8.96 (distress)
- Working capital / assets 0.75
- Retained earnings / assets -4.123
- EBIT / assets -0.529
- Equity / liabilities 2.971
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001725160 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.